A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors) November 19, 2019By
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers August 26, 2019By
A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas February 12, 2019By
Family, Friends, and Medical Marijuana — Karen Balik on How She Got Through Cancer November 20, 2018By Laura Gesualdi
Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) July 2, 2018By
